Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medication Treatment and f-MRI in Depressed Outpatients
NCT00296777Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), persistent depressive disorder (PDD), sponsored by New York State Psychiatric Institute. Started Dec 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00296777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296777.